ahead action health diabetes design methods clinical trial weight loss prevention cardiovascular disease pubmed ncbi abstract overweight obesity major contributors type num diabetes cardiovascular disease cvd individuals type num diabetes overweight obese high risk cvd morbidity mortality short-term weight loss shown ameliorate obesity-related metabolic abnormalities cvd risk factors long-term consequences intentional weight loss overweight obese individuals type num diabetes adequately examined primary objective ahead clinical trial assess long-term effects num years intensive weight loss program delivered num years overweight obese individuals type num diabetes approximately num male female participants type num diabetes num years age body mass index num kg/m num randomized groups intensive lifestyle intervention designed achieve maintain weight loss decreased caloric intake increased physical activity program compared control condition diabetes support education primary study outcome time incidence major cvd event study designed provide num probability detecting num difference major cvd event rates groups outcomes include components cvd risk cost cost-effectiveness diabetes control complications hospitalizations intervention processes quality life 
